In addition, overexpression of TFEB has been reported to be beneficial in numerous disease models via clearance of aggregated protein (e.g., tau in Alzheimer's, α-syn in Parkinson's, and HTT in Huntington's [325–327]). This evidence concerns the gene MAPT and Parkinson disease.